Boston Scientific just committed $138 million to Hendricks County — and for Indiana device suppliers and regional manufacturers, the announcement carries more operational weight than a standard investment headline would suggest.

Watch this TEG Daily on YouTube.

Boston Scientific's Plainfield Facility Is a Compliance Anchor, Not Just a Warehouse

Boston Scientific is building a 500,000-square-foot global medical device distribution and light manufacturing facility at Plainfield Innovation Park. The IEDC committed a $5.5 million performance-based incentive package. Up to 300 jobs. Groundbreaking expected later this year.

Here's what the headline skips: this isn't a facility that relocates in three years. It embeds regulatory compliance operations. Moving an FDA-registered facility requires re-registration, revalidation of quality systems, and customer requalification. That process takes the better part of a decade. For existing Indiana device suppliers, that's a structural anchor in the regional ecosystem.

The question worth modeling: at $460,000 in capital per employee, this is a heavily automated footprint. Boston Scientific's 2025 annual report describes embedding R&D into plants and infusing AI and automation throughout its global supply chain. A facility that size and capital intensity could eventually pull work currently contracted to regional suppliers. Don't assume current contract volume is permanent structure.

One signal to watch: whether Boston Scientific files with the FDA as a distribution facility or a manufacturing establishment. That filing tells you whether this stays a logistics hub or starts pulling production in-house. Plainfield's industrial corridor is reportedly at 97% occupancy — vendors competing to locate adjacent will face tighter land and lease costs.

Ivy Tech Muncie's Workforce Numbers Have a December 1 Deadline Attached

Ivy Tech Muncie's School of Advanced Manufacturing, Engineering, and Applied Science posted 94% growth in completions year over year. Workforce training enrollment hit 1,003 students, up 62%. The Cohen Road Advanced Technology Center is serving Delaware, Henry, and Jay counties.

The operationally relevant fact isn't the growth. It's what Senate Enrolled Act 254 — signed by Governor Braun on March 5th — triggers starting July 1st. Ivy Tech is now Indiana's statutory workforce engine. The IEDC has until December 1st to build an education-to-employment data framework. Once IEDC has employer-campus training volume at the deal-scoring stage, it's hard to imagine they won't weight it.

Manufacturers partnered with the Muncie Manufacturing Alliance's Ivy Tech Consortium get early access to that credentialed pipeline. Manufacturers who aren't engaged compete for the same candidates without that advantage. Get someone into that conversation before the framework is finalized — not after.

May's PMI and Factory Orders Require Qualification Before You Use Them

The ISM Manufacturing PMI came in at 54.0 for May 2026 — a four-year high, fifth consecutive month of expansion. Factory orders surged 4.8% in April to $62.7 billion, the largest monthly gain since May 2025. Both numbers look strong. Both require significant qualification.

On the PMI: 42% of ISM respondents directly cited the Iran conflict, and 69% of comments were negative. The supplier deliveries index hit 60.6%, its highest since 2022 — that signals delivery slowdowns, not demand strength. The prices paid index held at 82.1. The expansion is being driven by defensive stockpiling ahead of tariff and supply disruption risk, not organic demand growth. When those inventories normalize, expect a PMI air pocket in Q3 or Q4.

On factory orders: the 4.8% headline is almost entirely a Boeing story. Commercial aircraft orders surged 165.9% after Boeing's best monthly gross order total of 2026. Outside that, non-defense capital goods excluding aircraft — the metric that tracks broad business investment — declined 1% in April, missing even the modest 0.4% forecast. Machinery orders rose only 0.7%. If your order book looks strong right now, audit how much of it traces to customer restocking versus genuine end-user demand before you build Q3 and Q4 assumptions on it.

Questions for Your Morning Huddle

Q: Our team supplies into Indiana's medical device market. Should we be concerned about the Boston Scientific Plainfield build? A: Not immediately — but model the scenario where a heavily automated facility at $460,000 per job eventually pulls contracted work in-house. Watch whether Boston Scientific's FDA filing classifies the Plainfield site as distribution or manufacturing. That classification is the signal worth tracking.

Q: We're in east central Indiana. What should we actually do about the Ivy Tech Muncie news? A: Get someone into an active partnership conversation with the Muncie Manufacturing Alliance's Ivy Tech Consortium before December 1st. Once the IEDC's education-to-employment data framework is finalized, your positioning is already set. Act before the scoring criteria are locked.

Q: Our procurement team is using the May PMI to justify inventory decisions. Is that a problem? A: Yes, if they're reading 54.0 as organic demand growth. The expansion is being driven by defensive stockpiling and a Boeing surge that doesn't reflect durable demand. Audit your order book against restocking cycles versus actual end-user demand before committing Q3 and Q4 assumptions to it.

If the energy cost side of your Indiana manufacturing footprint is on your radar, the TEG Energy Decision Blueprint is the right starting point for getting your arms around rate exposure and operational risk. Watch this TEG Daily on YouTube.